Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

BACKGROUND: Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Shahi Salman, Rustam, Minks, David P, Mitra, Dipayan, Rodrigues, Mark A, Bhatnagar, Priya, du Plessis, Johann C, Joshi, Yogish, Dennis, Martin S, Murray, Gordon D, Newby, David E, Sandercock, Peter A G, Sprigg, Nikola, Stephen, Jacqueline, Sudlow, Cathie L M, Werring, David J, Whiteley, William N, Wardlaw, Joanna M, White, Philip M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645733/
https://www.ncbi.nlm.nih.gov/pubmed/31129065
http://dx.doi.org/10.1016/S1474-4422(19)30184-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645733/
https://www.ncbi.nlm.nih.gov/pubmed/31129065
http://dx.doi.org/10.1016/S1474-4422(19)30184-X

Ejemplares similares